BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CARD11, BIMP3, 84433, ENSG00000198286, CARMA1, MGC133069, Q9BXL7
7 results:

  • 1. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in
    Hu G; Hauk PJ; Zhang N; Elsegeiny W; Guardia CM; Kullas A; Crosby K; Deterding RR; Schedel M; Reynolds P; Abbott JK; Knight V; Pittaluga S; Raffeld M; Rosenzweig SD; Bonifacino JS; Uzel G; Williamson PR; Gelfand EW
    Autophagy; 2023 Feb; 19(2):678-691. PubMed ID: 35838483
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma.
    Nie GJ; Liu J; Zou AM; Zhan SF; Liang JK; Sui Y; Chen YN; Yao WS
    J Clin Lab Anal; 2022 Apr; 36(4):e24277. PubMed ID: 35238419
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gene Body Methylation of the Lymphocyte-Specific Gene
    McGuire MH; Dasari SK; Yao H; Wen Y; Mangala LS; Bayraktar E; Ma W; Ivan C; Shoshan E; Wu SY; Jonasch E; Bar-Eli M; Wang J; Baggerly KA; Sood AK
    Mol Cancer Res; 2021 Nov; 19(11):1917-1928. PubMed ID: 34348992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.
    Narita Y; Nagane M; Mishima K; Terui Y; Arakawa Y; Yonezawa H; Asai K; Fukuhara N; Sugiyama K; Shinojima N; Kitagawa J; Aoi A; Nishikawa R
    Neuro Oncol; 2021 Jan; 23(1):122-133. PubMed ID: 32583848
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.
    Yang Y; Schmitz R; Mitala J; Whiting A; Xiao W; Ceribelli M; Wright GW; Zhao H; Yang Y; Xu W; Rosenwald A; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Wiestner A; Kruhlak MJ; Iwai K; Bernal F; Staudt LM
    Cancer Discov; 2014 Apr; 4(4):480-93. PubMed ID: 24491438
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. B-cell receptor signaling as a driver of lymphoma development and evolution.
    Niemann CU; Wiestner A
    Semin Cancer Biol; 2013 Dec; 23(6):410-21. PubMed ID: 24060900
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. carma1 controls Th2 cell-specific cytokine expression through regulating JunB and GATA3 transcription factors.
    Blonska M; Joo D; Zweidler-McKay PA; Zhao Q; Lin X
    J Immunol; 2012 Apr; 188(7):3160-8. PubMed ID: 22371397
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.